AVEO Oncology
AVEO
#7323
Rank
NZ$0.95 B
Marketcap
NZ$27.42
Share price
0.00%
Change (1 day)
177.92%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -NZ$44.46 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are NZ$94.31 Million. In 2021 the company made an earning of -NZ$97.51 Million a decrease over its 2020 earnings that were of -NZ$65.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$44.46 Million-54.41%
2021 -NZ$97.51 Million49.9%
2020 -NZ$65.05 Million-479.04%
2019 NZ$17.16 M-276.17%
2018 -NZ$9.75 Million-91.79%
2017 -NZ$0.12 Billion142.38%
2016 -NZ$48.97 Million78.51%
2015 -NZ$27.43 Million-71.55%
2014 -NZ$96.41 Million-50.72%
2013 -NZ$0.2 Billion-4.88%
2012 -NZ$0.21 Billion-426.29%
2011 NZ$63.03 M-159.85%
2010 -NZ$0.11 Billion35.33%
2009 -NZ$77.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$63.55 B-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.20 B-38,159.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$0.81 B-1,632.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$10.39 B-19,683.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.71 B-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$4.13 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA